複製鏈接
請複製以下鏈接發送給好友

史萍

(華東理工大學生物反應器工程國家重點實驗室公共儀器平台負責人)

鎖定
史萍,博士,研究員。華東理工大學生物反應器工程國家重點實驗室公共儀器平台負責人,生物化學與分子生物學專業碩士研究生導師。曾主持、參與20多項部、省、市、校級課題,其中主持8項;發表與待發表學術論文近40篇,其中有23 篇發表在SCI收錄期刊; Atlas Genetics Oncology網站綜述一篇;會議摘要4篇。
中文名
史萍
國    籍
中國
民    族
漢族
性    別

史萍教育背景

1998-2001年 蘭州大學化學化工學院,博士
1995-1998年 蘭州大學生命科學學院,碩士

史萍工作經歷

2006.4-2009.9:美國德克薩斯大學MD Anderson腫瘤中心病理學系從事博士後研究工作
2003.7-2006.4:華東理工大學生物工程學院,生物反應器工程國家重點實驗室,副研究員
2001.7-2003.7:廈門大學生命科學學院,生物化學與分子生物學方向從事博士後研究工作

史萍學術兼職

2005.1-至今:中國科學院西北高原生物研究所客座研究人員
2002-年至今:中國細胞生物學會會員
2007-年至今:美國腫瘤研究協會會員,美國腫瘤研究協會婦女科研工作者協會會員
Protomics審稿人
Journal of Cellular and Molecular Medicine審稿人
Chemico-Biological Interactions審稿人
Zoology審稿人
Turkish Journal of Zoology審稿人

史萍研究方向

生物反應過程細胞信號傳導研究
生物活性小分子的細胞機制研究
腫瘤分子標記(物)分析 [1] 

史萍研究成果

一、期刊論文(*通訊作者):
Li M, Zhu P, Huang Z, Huang Y, Lv X, Zheng Q, Zhu Z, Fan Z, Yang Y*, Shi P*. Aspirin damages the cell wall of Saccharomyces cerevisiae by inhibiting the expression and activity of dolichol-phosphate mannose synthase 1. FEBS Lett. 2022, 596(3):369-380.
Li M., Sun P, Dong K, Xin Y, Tailulu A, Li Q*, Sun J, Peng M, Shi P*. Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells. Arch. Pharm. Res. 2021, 44: 194–204.
Lv X, Zhang W, Xia S*, Huang Z, Shi P*. Clioquinol inhibits cell growth in a SERCA2‐dependent manner. J. Biochem. Mol. Toxicol. 2021, 35: e22727.
Chen N*, Zheng Q, Wan G, Guo F, Zeng X*, Shi P*. Impact of posttranslational modifications in pancreatic carcinogenesis and treatments. Cancer Metastasis Rev. 2021, 40:739–759.
Zhang Y, Yan C, Zheng Q, Jia Q, Wang Z, Shi P, Guo Z*. Harnessing Hypoxia-Dependent Cyanine Photocages for In Vivo Precision Drug Release. Angew. Chem. Int. Ed. 2021, 60: 2–11.
Huang Z*, Dai H, Zhang X, Wang Q, Sun J, Deng Y, Shi P. BSC2 induces multidrug resistance via contributing to the formation of biofilm in Saccharomyces cerevisiae. Cell. Microbiol. 2021, e13391.
Lv X, Zheng Q, Li M, Huang Z, Peng M, Sun J* and Shi P*. Clioquinol induces S-phase cell cycle arrest through the elevation of the calcium level in human neurotypic SH-SY5Y cells. Metallomics. 2020,12, 173-182.
Gao W, Li M, Xu G, Wang R, Shi B, Zhu T, Gao J, Gu X*, Shi P*, Zhao C*. Tumor microenvironment-activated nanosystems with selenophenol substituted BODIPYs as photosensitizers for photodynamic therapy. Bioorg. Med. Chem. Lett. 2020, 30(2): 126854.
Zhu P, Li M, Yan C, Sun J, Peng M, Huang Z*, Shi P*. Aspirin Causes Lipid Accumulation and Damage to Cell Membrane by Regulating DCI1 / OLE1 in Saccharomyces cerevisiae. Microb. Drug Resist. 2020, 26(8): 857-868.
Liu Y, Lv X, Xia S*, Hao B, Huang X, Shi P*. PEGylated graphene oxide as a nanocarrier of the disulfide prodrug of podophyllotoxin for cancer therapy. J. Nanopartic. Res. 2020,22:281.
Li M, Xia S*, Shi P*. DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma. PeerJ. 2020, 8: e10307.
Wang R, Dong K, Xu G, Shi Ben, Zhu T, Shi P*, Guo Z, Zhu W, Zhao C*. Activatable Near-Infrared Emission-Guided On-Demand Administration of Photodynamic Anticancer Therapy with a Theranostic Nanoprobe. Chem. Sci. 2019, 10: 2785-2790.
Zhang X, Wang S, Hu L, Wang J, Liu Y, Shi P*. Gemfibrozil reduces lipid accumulation in SMMC-7721 cells via the involvement of PPARαand SREBP1. Exp. Ther. Med. 2019, 17:1282-1289.
Xin Y, Dong K, Cao F, Tian Y, Sun J, Peng M, Liu W*, Shi P*. Studies of hTERT DNA methylation assays on the human age prediction. Int. J. Lagal Med. 2019, 113: 1333-1339.
George B , George S K , Shi W , Haque A , Shi P, Eskandari G, Axelson M, Larsson O, Kaseb A O, Amin H M*. Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+, T-cell lymphoma. J. Hematol. Oncol.2019, 12:8.
Dong K, Xin Y, Cao F, Huang Z, Sun J, Peng M, Liu W*, Shi P*. Succession of oral microbiota community as a tool to estimate postmortem interval. Sci. Rep. 2019, 9: 13063. [2] 
參考資料